ResMed: Facing A Potentially Dream-Disrupting Dose (NYSE:RMD)

ResMed ( RMD ) is a $37 billion powerhouse that sees itself as a "36-year-old startup" in the field of sleep and breathing health. It dominates as the #1 provider in 140+ countries with a 50–60% market share in sleep apnea devices like CPAP (“Continuous Positive Airway Pressure”) machines, masks, andAlways on the hunt for undervalued, promising stocks with a focus on risk and reward. Limited risks and decent to high upside by knowing what one's owning. I strongly believe that the best investment ideas are o ...